Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01023776 · ClinicalTrials.gov registry record · Phase 4
Infectivity, Replication & Immunogenicity of Live nH1N1 Vaccine
A Phase 4 study, sponsored by University of Rochester.
- Completed
- Registry status
- Phase 4
- Development phase
- 20
- Enrollment target
NCT01023776 is a Phase 4 study that has completed, run by University of Rochester. The registered enrollment target is 20 participants.
The verdict
NCT01023776, a Phase 4 study, has completed, sponsored by University of Rochester.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 20 participants
- Enrollment target
Study Summary
The purpose of the study is to determine the amount of live virus that can be recovered from the nose of people who are vaccinated with the licensed live vaccine against H1N1, and to describe the immune response to vaccination.
Interventions
- BIOLOGICAL A/California/07/09 live monovalent H1N1 vaccine
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2009-11 |
| Est. Completion | 2010-07 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01023776
The ClinicalTrials.gov registry entry for NCT01023776 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 20 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Rochester, which has 636 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which A/California/07/09 live monovalent H1N1 vaccine is the first listed.
NCT01023776 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01023776 about?
NCT01023776 is a clinical study titled "Infectivity, Replication & Immunogenicity of Live nH1N1 Vaccine". The purpose of the study is to determine the amount of live virus that can be recovered from the nose of people who are vaccinated with the licensed live vaccine against H1N1, and to describe the immune response to vaccination.
What is the current status of trial NCT01023776?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 20 participants. The study started on 2009-11. Estimated completion is 2010-07.
What interventions are being tested in trial NCT01023776?
The interventions under investigation include: A/California/07/09 live monovalent H1N1 vaccine (BIOLOGICAL).
Who is sponsoring clinical trial NCT01023776?
This trial is sponsored by University of Rochester, which has 636 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.